###### Strengths and limitations of this study

-   Although daily consultant ward rounds have been reported in the USA and Canada, our paper reports for the first time the impact of daily senior clinician input on increasing patient throughput while significantly reducing investigation and pharmacy costs. In addition, the Academy of Medical Royal Colleges has recently reported a potential savings on £11.7 million from our model of care.

-   Our study demonstrates sustained cost savings over 2 years and the savings are reproducible on medical wards where twice-weekly consultant wards still persist.

-   We have shown that daily consultant ward rounds can be achieved by changing the way we work without incurring extra costs while reducing inappropriate investigations and medication use, which is demonstrated by the unchanged readmission and mortality rate despite almost doubling the patient throughput.

-   The study, however, only took into account the most common investigations, but given the significant reduction in investigations demonstrated, it is likely that we would have identified further cost savings if all investigations were included.

-   Although our study demonstrates a reduction in investigations, the net cost savings would also be dependent on bed base and staff reduction in the respective departments. It can be argued that in the absence of bed base or staff reduction, no actual money was saved but wide spread implementation of daily consultant ward rounds in the future would allow these departments to incorporate changes in the way they work.

Introduction {#s1}
============

The overuse of investigations in clinical medicine has been discussed over the past four decades[@R1] and has been consistently increasing. There is little evidence that quality of care has proportionately improved,[@R2] yet the burden on healthcare resources has substantially increased.[@R3] More importantly, only 1% of haematological and less than 10% of other investigations were shown to contribute to a diagnosis suggesting investigations should be ordered responsibly.[@R4] [@R5] Furthermore, excessive and inappropriate investigations can lead to further tests and physicians treating the results rather than the patient.[@R6] [@R7]

Various reasons including lack of training and supervision of junior staff have been suggested for the inappropriate use and duplication of investigations.[@R2] [@R3] [@R7] The cost of investigations can range from £5 to few hundred pounds per test, with a substantial cost implication if used inappropriately in hospital settings with high patient throughput (PT). Cost containment strategies focused on clinician education, cost awareness, use of computer models, feedback and other aspects have led to wastage reduction but were either not sustainable or incurred an ongoing cost.[@R15]

Inappropriate use of medication is another source of resource wastage and has direct cost implications with cost savings demonstrated by implementing restriction or management policies,[@R18] which again required extra resources and ongoing educational costs.

Delays in investigational procedures and inappropriate use of medication have been highlighted as factors leading to prolonged of length of stay (LoS).[@R22] Senior clinician input has been shown to reduce LoS.[@R23] It is proposed that the reduced LoS and bed days is associated with significant cost savings.[@R25]

The current study aims to look at the impact of twice-daily consultant ward rounds on the number of investigations performed and the pharmacy costs compared with the traditional twice-weekly ward rounds.

Methods {#s2}
=======

Hospital setting {#s2a}
----------------

The study was conducted on two general medical wards with a mixed case load of admissions from the acute admissions unit, A&E and the clinics at the Royal Liverpool University Teaching hospital. The two wards are covered by four consultants and their teams, described elsewhere.[@R23]

Cost-benefit analysis {#s2b}
---------------------

We performed a cost-benefit analysis of the impact of twice-daily consultant wards on the use of investigations and medication on our two busy medical wards. The main outcome measure was the per patient annual financial cost benefit of twice-daily compared with the traditional twice-weekly consultant ward rounds over a 2-year period. Since the only intervention was a change in consultant working pattern with the same number of sessions, team structure and experience, same number of staff on the wards with no extra costs incurred and no change in overheads, we were able to estimate the net change in the use of investigations and its financial costs before and after the intervention.

Intervention {#s2c}
------------

Following detailed team discussions and job planning negotiations, the working pattern of the four consultants responsible for two general medical wards was completely changed from a traditional twice-weekly to twice-daily ward rounds and a week-on the ward and a week-off the ward job plan. This change provided daily consultant input in clinical decision-making as well as daily bedside teaching and supervision of junior staff and monitoring their investigation requesting and prescribing habits while keeping the staff costs neutral. The details of the changeover are described elsewhere.[@R23]

Data collection {#s2d}
---------------

The intervention was implemented on 1 November 2009. All data were collected by the hospital information department on a daily basis and reported on a monthly basis. To ensure sustainability of the intervention and reliability of the results, data were collected for the 2-year period following the intervention. LoS, readmission rates (RRs) and mortality rates (MRs) were obtained for the two wards. Their definitions are described elsewhere.[@R23] RR and MR data were obtained to assess any adverse effects on the quality of patient care.[@R15] PT was the patient intake and flow through both wards over the study period and was collected to calculate the investigation and pharmacy cost per patient. The same data were also collected for the 2-year period preceding the intervention to estimate the benefit of the intervention.

The investigations studied included biochemistry (urea and electrolytes and liver function tests), full blood count, chest X-ray (CXR), CT, MRI, ventilation/perfusion scan (V/Q), endoscopy (oesophogogastroduodenoscopy and colonoscopy). These represent the most commonly requested investigations by our wards from clinical chemistry, radiology, nuclear medicine and gastroenterology departments over the 4-year period. The total number of each investigation used between 1 November 2007 and 31 October 2011, and the cost of each investigation was provided by the respective departments. We also obtained the annual pharmacy costs for the same 4-year period from the pharmacy department. These figures were confirmed by the Royal Liverpool Hospital\'s finance department. Other investigations such as ECGs, C reactive proteins (CRPs), echocardiograms, etc, were not included as most of these were requested by the emergency and acute medical admission units prior to the patients' arrival on our wards.

Data analysis {#s2e}
-------------

The monthly mean for PT, LoS, RR, MR and investigations performed was calculated for the 2 years prior to and following the intervention. The annual mean PT was calculated to determine annual cost savings for the period following the intervention.

Per patient monthly mean investigations were then calculated by dividing the mean investigations by the mean PT for the 2 years prior to and following the intervention. Per patient mean monthly investigation was then multiplied with the unit cost of each investigation to obtain per patient mean monthly cost for each investigation. Per patient mean annual pharmacy cost was calculated by dividing the mean annual pharmacy cost by the mean annual PT for the two wards and reported as monthly mean for uniformity.

Cost saving benefit was then calculated by finding the difference between the mean per patient cost before and after the intervention. Finally, to calculate the total annual cost saving the mean per patient cost saving for each investigation and the pharmacy was multiplied with the mean annual PT number after the intervention. The results are reported as means±SD.

Since the working hours of staff and the number of clinics were unaffected, these costs remained neutral and therefore were not included. Similarly the cost for ward overheads was not included as the wards remained fully functional throughout the study period and were not affected by the intervention. The cost saving calculations and the potential savings from reduced bed days and LoS we reported in our previous paper[@R23] was beyond the scope of this study.

Statistical analysis {#s2f}
--------------------

Statistical analysis was performed using one-way analysis of variance, and where multiple comparisons were made, Tukey and Dunnett\'s C test was applied depending on equal or unequal variances, respectively. The p value \<0.05 was considered significant. Results are expressed as means±SD.

Results {#s3}
=======

The annual means±SD of PT, LoS, RR and MR are shown in [table 1](#BMJOPEN2014007367TB1){ref-type="table"}, which demonstrates a significant increase in PT and reduction in LoS following the intervention. Importantly, the RR and MR did not change significantly despite the increase in patient flow through the wards.

###### 

Comparison of monthly mean of patient throughput, length of stay, readmission rate and mortality rate prior to and after the intervention

  Variable                            Monthly mean (2007--2009)   Monthly mean (2009--2011)
  ----------------------------------- --------------------------- ---------------------------
  Patients throughput (annual mean)   152.2±23.7 (1827)           259.7±24.0 (3116)\*
  Length of stay (days)               9.7±1.7                     5.2±0.5\*
  Readmission rate (%)                18.8±2.1%                   19.3±2.4%^NS^
  Mortality (%)                       2.9±1.4%                    2.7±1.3%^NS^

\*p\<0.01, ^NS^p=not significant.

The monthly mean investigations, annual pharmacy costs, per patient investigation and pharmacy cost with annual cost savings are shown in [table 2](#BMJOPEN2014007367TB2){ref-type="table"}. Our report shows that despite the significant increase in patient flow, the daily consultant input led to a 50% reduction in the mean per patient investigations and pharmacy costs. The annual mean net cost saving benefit from reducing the investigations and pharmacy cost was £336 528 per year and a total of £673 056 over the 2-year study period.

###### 

Comparison of mean monthly investigations, pharmacy and per patient cost with calculated annual cost savings prior to and after the intervention

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Investigations (cost per unit)   Monthly mean (2007--2009)   Monthly mean (2009--2011)   Per patient monthly mean\   Per patient monthly mean\   Mean cost saving per patient   Mean annual cost saving for the period\
                                                                                           2007--2009\                 2009--2011 (cost)                                          2009--2011
                                                                                           (cost)                                                                                 
  -------------------------------- --------------------------- --------------------------- --------------------------- --------------------------- ------------------------------ -----------------------------------------
  Biochemistry (£5)                1007.2±112.4                834.5±134.4                 6.6±1.2 (£33)               3.2±0.9 (£16)\*             £17                            £52 972

  FBC (£5)                         423.9±27.9                  326.7±28.3                  2.8±0.5 (£14)               1.2±0.2 (£6)\*              £8                             £24 928

  CT (£228)                        17.3±6.1                    16.7±6.0                    0.12±0.04 (£27)             0.06±0.02 (£14)\*           £13                            £40 508

  MRI (£460)                       3.6±2.6                     3.1±1.7                     0.02±0.01 (£9)              0.01±0.007 (£5)\*           £4                             £12 464

  CXR (£30)                        36.0±8.4                    32.3±8.0                    0.24±0.07 (£7)              0.12±0.03 (£4)\*            £3                             £9348

  V/Q scan (£271)                  7.3±3.0                     6.8±2.6                     0.05±0.07 (£14)             0.03±0.01 (£8)\*            £6                             £18 696

  Endoscopy (£492)                 20.5±5.8                    16.7±5.5                    0.13±0.03 (£64)             0.06±0.02 (£29)\*           £35                            £109 060

  Pharmacy (annual cost)           (£84 919)                   (£75 518)                   £46                         £24                         £22                            £68 552

  Total cost                       --                          --                          --                          --                          £108                           £336 528
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*p\<0.01.

CXR, chest X-ray; FBC, full blood count; V/Q, ventilation/perfusion.

Discussion {#s4}
==========

This study shows that consultant ward rounds and decision-making significantly reduces the use of inappropriate investigations, pharmacy costs and LoS, resulting in a significant, sustainable year-on-year cost savings in excess of £300K. Our per patient investigation and pharmacy costs were halved and sustained over a 2-year period. More importantly, reducing the number of investigations and pharmacy use did not result in increased RRs or inpatient mortality. This study does not include the potential savings from reducing the LoS and inpatient bed days.

Overuse of investigations leading to resource wastage has been highlighted from as early as 1979.[@R1] There is very little evidence that excessive testing improves diagnostic accuracy or patient care[@R2] [@R4] [@R5] [@R7] and indeed may be harmful to patients due to misinterpretations and lead to further inappropriate testing or even potentially harmful clinical interventions.[@R7] Several reasons for the variation and continued increase in investigations have been offered including ease of access to tests, lack of training, uncertainty of diagnosis, defensive medicine, increased patient turnover and excessive monitoring.[@R2] [@R7] The clinical and educational inexperience of doctors is considered one of the important factors for inappropriate tests being ordered.[@R17] [@R26] [@R27] The test ordering behaviour of doctors significantly changed by introducing guidance in the form of simple form and computer-based requests.[@R14] [@R15] Numerical rationing,[@R2] notifying doctors of their test usage compared with their peers,[@R28] informing physicians of the test costs,[@R29] [@R30] introducing investigation requesting protocols[@R31] and education of clinical staff[@R32] have all shown to reduce inappropriate investigations. However, senior clinician input in the form of auditing the intern\'s charts weekly led to a 50% reduction in investigations.[@R33] Our study has similarly demonstrated that daily consultant input can lead to a 50% reduction in unnecessary testing without compromising patient safety.

Although the various strategies used to reduce overuse of investigations demonstrated cost benefits, their implementation has cost implications and are difficult to sustain.[@R15] Developing paper-based or computer-based request forms or computer-based models in itself require funding but, furthermore, need ongoing educational programmes to cope with the rapid turnover of junior doctors to ensure proper use of these models on a consistent basis.[@R13] Similarly, developing and running ongoing educational programmes to promote optimal use of investigations requires senior clinician time in addition to other cost implications, while there are some questions on the value of such programmes.[@R17] [@R34] Introducing investigation requesting protocols can be useful in reducing investigations but arguably can lead to unnecessary testing in patients who clinically may not need them.[@R7] [@R35] In our previous study,[@R23] we compared the impact of daily consultant ward rounds on LoS between our and two other wards with similar case load and demonstrated halving of the LoS on our wards, whereas, the LoS essentially remained unchanged on those two wards practising the traditional twice-weekly consultant ward rounds. While most hospitals[@R36] including ours have been reporting a year on year increase in the use of investigations, our model of consultant working pattern allowing daily senior clinician input into clinical decision-making led to a reduction in investigations without any extra costs and obviated the need for developing special requesting models or ongoing educational programmes requiring extra clinician teaching time. We were able to provide relevant and focused bedside teaching and supervision to the junior doctors on appropriate use of investigations and help them understand results interpretation. Our model has led to considerable cost savings while preventing patient discomfort or compromising quality of care.

It is debateable whether the reduced LoS we observed following twice-daily ward rounds was due to a reduction in unnecessary tests which caused delayed discharges, or if reducing LoS by better senior clinician\'s decision-making led to a decrease in unnecessary testing because of the considerably shorter stay of patients in the hospital. Evidence suggests that prolonged LoS leads to increased thromboembolic and hospital-acquired infection risk, which inevitably results in more investigations and treatment costs.[@R37] [@R38] Reducing the LoS has been shown to decrease infection risk,[@R39] comorbidities and mortality[@R37] and has an impact on clinical outcomes.[@R40] Appropriate use of antibiotics helps reduce the LoS.[@R41] These measures impact on pharmacy costs, which is another major resource wastage in hospital medical care. Doctors lack of understanding and knowledge plays a role in inappropriate use of antibiotics and education programmes, and restriction policies have shown to improve appropriate use of antibiotics.[@R21] [@R42] [@R43] Similar to strategies employed in reducing investigations, the educational programmes required to implement these policies are labour intensive and time consuming with cost implications.[@R21] The halving of LoS we achieved by daily consultant ward rounds may have contributed significantly in reducing the pharmacy costs by a combination of reducing hospital-acquired infections and appropriate use of antibiotics by providing daily supervision and guidance to junior doctors.

We anticipate that the savings reported in this study are an underestimation of the total potential savings since all the resources groups used on the wards, such as cardiology resources (eg, ECG, echocardiogram), microbiology or other blood tests (eg, thyroid function tests, CRP), were not included as they were either already ordered and performed in the admission units or by the specialist teams reviewing these patients on our request. In addition, societal costs, patient satisfaction, quality of life and the potentially reduced hospital-acquired morbidities because of the reduced LoS were beyond the scope of the study but may have highlighted further significant cost savings. The financial implications of reducing the number of bed days per patient have to be considered. It can be argued that in the absence of bed base or staff reduction, no actual money was saved. However, the recent report from the Academy of Medical Royal Colleges, based on our previous study,[@R23] has suggested a potential saving of £11.7 million and a reduction of 1900 tonnes of carbon per year by reducing the LoS and bed days using our model.[@R23] [@R25] Although our model was implemented on only two medical wards, the case mix is similar to most medical wards in most hospitals.

Although various strategies used to reduce investigations and pharmacy costs demonstrated cost savings,[@R14] [@R15] [@R27] they either had cost implications of developing and providing ongoing education to staff, lacked sustainability because of the rapid junior doctor turn over or were even detrimental to clinical decision-making.[@R15] Almost all approaches are centred on reducing investigations whereas our study method is based on a change in consultant working pattern allowing senior clinical input and decision-making on a daily basis improving clinical diagnosis, which in turn has led to reduced investigations and reducing LoS. This is a more holistic approach allowing daily education of staff, supervising the use of tests and medications while improving clinical decision-making that has led to a 50% reduction in LoS, investigations and pharmacy laboratory costs saving in excess of £300K per year. This is not only sustainable and reproducible but has very little cost implications if properly implemented.
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